Kraig Biocraft Laboratories Inc (KBLB)

[ZincFinger]

What you fail to understand is that it is entirely normal and expected for some genetic variations to "conflict" with the GMs made and also for them to be weeded out as a natural consequence of the ramping up of the population EVEN IN THE ABSENCE OF DIRECTED SELECTION. Those variations that "conflict" with the genetic modifications reproduce less efficiently than those compatible with them, so as the population gets ramped up, the lines become progressively more efficient. (Epigenetic modifications are also involved in the process but that's far above the level of most here.)

I do not know of any biotech whatsoever (and defy anyone to mention even a single example) that PR's routine and expected problems that occur during the course of product development and that have standard and routine solutions.

PS: a 30% reproduction rate is entirely acceptable for silkworm production (their rate is 100 to 200X per generation and the cost of raising and reproducing them is very low and only a very small fraction of production costs (which are overwhelmingly reeling and spinning). So a 30 to 60X reproduction rate would have been entirely workable.

The cost of production is essentially the same as for normal silk and far lower than the value of the high tech product so minor variations in the cost of production will not even show up in the first couple of digits of revenues.

In any event your argument is a total non sequiter because production uniformity is totally unrelated to the reproduction rate.